EP
IDYA icon

Essential Partners’s IDEAYA Biosciences IDYA Stock Holding History

Essential Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15K Hold
30
– – ﹤0.01% 2134
2026
Q2 		$1.12K Buy
30
+25
+500% +$765 ﹤0.01% 2194
2026
Q1 		$167 Hold
5
– – ﹤0.01% 2645
2025
Q4 		$173 Hold
5
– – ﹤0.01% 2457
2025
Q3 		$136 Hold
5
– – ﹤0.01% 2458
2025
Q2 		$105 Buy
+5
New +$96 ﹤0.01% 2057

Other funds holding IDYA

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $590M AUM 11.27% 1-Year Est. Return
CIA
Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

Essential Partners's IDYA Position: Q3 2026 in Review

Essential Partners held its IDEAYA Biosciences (IDYA) position steady in Q3 2026 at 30 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Essential Partners first reported a position in IDYA in Q2 2025 and has held it in 6 quarters since. 20 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Essential Partners held 30 shares of IDEAYA Biosciences worth $1.15K as of Q3 2026.
  • Essential Partners left its IDEAYA Biosciences share count unchanged in Q3 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2134 holding.
  • Essential Partners first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 6 quarters since.
  • 20 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.